Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $13,147 - $15,211
364 Added 6.93%
5,616 $205,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $23,712 - $30,870
-602 Reduced 10.28%
5,252 $214,000
Q4 2022

Feb 09, 2023

SELL
$41.75 - $54.5 $65,004 - $84,856
-1,557 Reduced 21.01%
5,854 $300,000
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $1,706 - $2,083
39 Added 0.53%
7,411 $324,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $17,541 - $20,799
377 Added 5.39%
7,372 $386,000
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $1,692 - $2,097
37 Added 0.53%
6,995 $362,000
Q4 2021

Jan 25, 2022

SELL
$41.32 - $61.25 $8,346 - $12,372
-202 Reduced 2.82%
6,958 $411,000
Q3 2021

Oct 27, 2021

BUY
$39.25 - $50.42 $39 - $50
1 Added 0.01%
7,160 $308,000
Q2 2021

Aug 04, 2021

BUY
$35.91 - $40.68 $143 - $162
4 Added 0.06%
7,159 $280,000
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $1,004 - $1,133
-30 Reduced 0.42%
7,155 $260,000
Q4 2020

Feb 10, 2021

BUY
$33.47 - $42.56 $240,481 - $305,793
7,185 New
7,185 $265,000
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $164,366 - $213,135
-5,059 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $187,081 - $210,049
5,059 New
5,059 $219,000
Q1 2019

May 08, 2019

SELL
$37.5 - $41.2 $171,187 - $188,078
-4,565 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$38.47 - $43.86 $1,269 - $1,447
-33 Reduced 0.72%
4,565 $200,000
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $158,493 - $192,242
4,598 New
4,598 $203,000
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $186,402 - $198,724
-5,652 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$31.91 - $37.02 $180,355 - $209,237
5,652 New
5,652 $200,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Trellis Advisors, LLC Portfolio

Follow Trellis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellis Advisors, LLC with notifications on news.